Barry D. Quart - Jun 29, 2021 Form 4 Insider Report for Kiniksa Pharmaceuticals, Ltd. (KNSA)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KNSA	Share Option	Award	$0	+33.2K		$0.00	33.2K	Jun 29, 2021	Class A Common Shares	33.2K	$14.33	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of grant. The date of grant is June 29, 2021.